Evaluation of modified non-overt DIC criteria on the prediction of poor outcome in patients with sepsis

Thrombosis Research

Volumn 126, Issue 1, 2010, Pages 18-23

  Oh, D ^a   Jang, M J ^a   Lee, S J ^a   Chong, S Y ^a   Kang, M S ^a   Wada, H ^b  

^a CHA University   (South Korea)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diagnosis; Disseminated intravascular coagulation (DIC); Sepsis

Indexed keywords

ALBUMIN; ANTITHROMBIN; BILIRUBIN; CREATININE; D DIMER; PROTEIN C; ANTITHROMBIN III; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; AGED; ALBUMIN BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART FAILURE; HUMAN; INFECTION; INTERNATIONAL SOCIETY ON THROMBOSIS AND HEMOSTASIS; KIDNEY FAILURE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON OVERT DISSEMINATED INTRAVASCULAR CLOTTING; ORGAN SYSTEM FAILURE SCORING; OUTCOME ASSESSMENT; OVERT DISSEMINATED INTRAVASCULAR CLOTTING; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY FAILURE; SCORING SYSTEM; SEPSIS; THROMBOCYTE COUNT; VALIDITY; BLOOD; DIAGNOSTIC USE; DISSEMINATED INTRAVASCULAR COAGULATION; HEMOSTASIS; MIDDLE AGED; THROMBOSIS; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTITHROMBIN III; ANTITHROMBINS; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; PROGNOSIS; PROTEIN C; PROTHROMBIN TIME; ROC CURVE; SEPSIS; THROMBOSIS; TREATMENT OUTCOME;

EID: 77953121064     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.12.008     Document Type: Article

References (20)

1. Taylor Jr. F.B., Toh C.H., Hoots W.K., Wada H., and Levi M. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86 (2001) 1327-1330
2. Levi M., and ten Cate H. Disseminated intravascular coagulation. N Engl J Med 341 (1999) 586-592
3. Gando S., Kameue T., Nanzaki S., and Nakanishi Y. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost 75 (1996) 224-228
4. Bernard G.R., Vincent J.L., Laterre P.F., LaRosa S.P., Dhainaut J.-F., Lopez-Rodriguez A., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344 (2001) 699-709
5. Warren B.L., Eid A., Singer P., Pillay S.S., Carl P., Novak I., et al. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286 (2001) 1869-1878
6. Dhainaut J.F., Yan S.B., Joyce D.E., Pettilä V., Basson B., Brandt J.T., et al. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2 (2004) 1924-1933
7. Kienast J., Juers M., Wiedermann C.J., Hoffmann J.N., Ostermann H., Strauss R., et al. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 4 (2005) 90-97
8. Angstwurm M.W., Dempfle C.E., and Spannagl M. New disseminated intravascular coagulation score: A useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores. Crit Care Med 34 (2006) 314-320
9. Okabayashi K., Wada H., Ohta S., Shiku H., Nobori T., and Maruyama K. Hemostatic markers and Sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit. Am J Hematol 76 (2004) 225-229
10. Dematte D'Amico J.E., Donnelly H.K., Mutlu G.M., Feinglass J., Jovanovic B.D., and Ndukwu I.M. Risk assessment for inpatient survival in the long-term acute care setting after prolonged critical illness. Chest 124 (2003) 1039-1045
11. Bone R.C., Balk R.A., and Cerra F.B. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 (1992) 1644-1655
12. Toh C.H., and Downey C. Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation. Blood Coagul Fibrinolysis 16 (2005) 69-74
13. Asakura H., Wada H., Okamoto K., Iba T., Uchiyama T., Eguchi Y., et al. Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections. Thromb Haemost 95 (2006) 282-287
14. Kobayashi A., Matsuda Y., Mitani M., Makino Y., and Ohta H. Assessment of the Usefulness of Antithrombin-III in the Management of Disseminated Intravascular Coagulation in Obstetrically Ill Patients. Clin Appl Thromb Hemost (2009) [Electronic publication ahead of print]
15. Voves C., Wuillemin W.A., and Zeerleder S. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients. Blood Coagul Fibrinolysis 17 (2006) 445-451
16. Wada H., Sakuragawa N., Mori Y., Takagi M., Nakasaki T., Shimura M., et al. Hemostatic molecular markers before the onset of disseminated intravascular coagulation. Am J Hematol 60 (1999) 273-278
17. Wada H., Minamikawa K., Wakita Y., Nakase T., Kaneko T., Ohiwa M., et al. Hemostatic study before onset of disseminated intravascular coagulation. Am J Hematol 43 (1993) 190-194
18. Wada H., Wakita Y., Nakase T., Shimura M., Hiyoyama K., Nagaya S., et al. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group. Thromb Haemost 74 (1995) 848-852
19. Kinasewitz G.T., Zein J.G., Lee G.L., Nazir S.A., and Taylor Jr. F.B. Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis. Crit Care Med 33 (2005) 2214-2221
20. Iba T., Gando S., Murata A., Kushimoto S., Saitoh D., Eguchi Y., et al. Japanese Association for Acute Medicine Disseminated Intravascular Coagulation Study Group.Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers. J Trauma 63 (2007) 1093-1098